2025-2031 Global AI in Biopharma Industry Research & Trends Analysis Report- YH Research

日本语 | 中文

Home > Reports >Pharma & Healthcare > 2025-2031 Global AI in Biopharma Industry Research & Trends Analysis Report

2025-2031 Global AI in Biopharma Industry Research & Trends Analysis Report

Publication Date: 2025-10-13
Report Id: 2507893
Industry: Pharma & Healthcare
Report Page: 117
Chart: 123

PDF Download

Publication Date: 2025-10-13
Report Id: 2507893
Industry: Pharma & Healthcare
Report Page: 117
Chart: 123

PDF Download

A research report provider that focuses on identifying industry pain points and solving core problems for companies！

Table of Contents
Description
Table of Figures
Need a Quote?

1 Market Overview
1.1 Product Overview and Scope of AI in Biopharma
1.2 Global AI in Biopharma Market Size and Forecast
1.3 China AI in Biopharma Market Size and Forecast
1.4 China Percentage in Global Market
1.4.1 By Revenue, China AI in Biopharma Share in Global Market, 2020-2031
1.4.2 AI in Biopharma Market Size: China VS Global, 2020-2031
1.5 AI in Biopharma Market Dynamics
1.5.1 AI in Biopharma Market Drivers
1.5.2 AI in Biopharma Market Restraints
1.5.3 AI in Biopharma Industry Trends
1.5.4 AI in Biopharma Industry Policy

2 Competitive Landscape by Company
2.1 Global AI in Biopharma Revenue by Company, 2020-2025
2.2 Global AI in Biopharma Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global AI in Biopharma Concentration Ratio
2.4 Global AI in Biopharma Mergers & Acquisitions, Expansion Plans
2.5 Global AI in Biopharma Manufacturers Product Type
2.6 Global Geographic Distribution of AI in Biopharma Companies

3 China Competitive Situation by Company
3.1 China AI in Biopharma Revenue by Company, 2020-2025
3.2 China AI in Biopharma AI in Biopharma Participants, Market Position (Tier 1, Tier 2, and Tier 3)
3.3 China AI in Biopharma Market, Revenue Percentage of Local Players VS Foreign Players (2020-2031)

4 Industry Chain Analysis
4.1 AI in Biopharma Industry Chain
4.2 AI in Biopharma Upstream Analysis
4.3 AI in Biopharma Midstream Analysis
4.4 AI in Biopharma Downstream Analysis

5 Sights by Type
5.1 AI in Biopharma Classification by Type
5.1.1 Machine Learning (ML) & Deep Learning (DL)
5.1.2 Natural Language Processing (NLP)
5.1.3 Others
5.2 by Type, Global AI in Biopharma Market Size & CAGR, 2020 VS 2024 VS 2031
5.3 by Type, Global AI in Biopharma Market Size, 2020-2031

6 Sights by Research Direction
6.1 AI in Biopharma Classification by Research Direction
6.1.1 Drug Discovery & Development
6.1.2 Genomics & Precision Medicine
6.1.3 Medical Imaging & Diagnostics
6.1.4 Others
6.2 by Research Direction, Global AI in Biopharma Market Size & CAGR, 2020 VS 2024 VS 2031
6.3 by Research Direction, Global AI in Biopharma Market Size, 2020-2031

7 Sights by Application
7.1 AI in Biopharma Segment by Application
7.1.1 Drug Development
7.1.2 Disease Diagnosis and Treatment
7.1.3 Other
7.2 by Application, Global AI in Biopharma Market Size & CAGR, 2020 VS 2024 VS 2031
7.3 by Application, Global AI in Biopharma Market Size, 2020-2031

8 Sights by Region
8.1 By Region, Global AI in Biopharma Market Size, 2020 VS 2024 VS 2031
8.2 By Region, Global AI in Biopharma Market Size, 2020-2031
8.3 North America
8.3.1 North America AI in Biopharma Market Size & Forecasts, 2020-2031
8.3.2 By Country, North America AI in Biopharma Market Size Market Share
8.4 Europe
8.4.1 Europe AI in Biopharma Market Size & Forecasts, 2020-2031
8.4.2 By Country, Europe AI in Biopharma Market Size Market Share
8.5 Asia Pacific
8.5.1 Asia Pacific AI in Biopharma Market Size & Forecasts, 2020-2031
8.5.2 By Country/Region, Asia Pacific AI in Biopharma Market Size Market Share
8.6 South America
8.6.1 South America AI in Biopharma Market Size & Forecasts, 2020-2031
8.6.2 By Country, South America AI in Biopharma Market Size Market Share
8.7 Middle East & Africa

9 Sights by Country Level
9.1 By Country, Global AI in Biopharma Market Size & CAGR，2020 VS 2024 VS 2031
9.2 By Country, Global AI in Biopharma Market Size, 2020-2031
9.3 United States
9.3.1 United States AI in Biopharma Market Size, 2020-2031
9.3.2 By Company, United States AI in Biopharma Revenue Market Share, 2024
9.3.3 by Type, United States AI in Biopharma Revenue Market Share, 2024 VS 2031
9.3.4 by Application, United States AI in Biopharma Revenue Market Share, 2024 VS 2031
9.4 Europe
9.4.1 Europe AI in Biopharma Market Size, 2020-2031
9.4.2 By Company, Europe AI in Biopharma Revenue Market Share, 2024
9.4.3 by Type, Europe AI in Biopharma Revenue Market Share, 2024 VS 2031
9.4.4 by Application, Europe AI in Biopharma Revenue Market Share, 2024 VS 2031
9.5 China
9.5.1 China AI in Biopharma Market Size, 2020-2031
9.5.2 By Company, China AI in Biopharma Revenue Market Share, 2024
9.5.3 by Type, China AI in Biopharma Revenue Market Share, 2024 VS 2031
9.5.4 by Application, China AI in Biopharma Revenue Market Share, 2024 VS 2031
9.6 Japan
9.6.1 Japan AI in Biopharma Market Size, 2020-2031
9.6.2 By Company, Japan AI in Biopharma Revenue Market Share, 2024
9.6.3 by Type, Japan AI in Biopharma Revenue Market Share, 2024 VS 2031
9.6.4 by Application, Japan AI in Biopharma Revenue Market Share, 2024 VS 2031
9.7 South Korea
9.7.1 South Korea AI in Biopharma Market Size, 2020-2031
9.7.2 By Company, South Korea AI in Biopharma Revenue Market Share, 2024
9.7.3 by Type, South Korea AI in Biopharma Revenue Market Share, 2024 VS 2031
9.7.4 by Application, South Korea AI in Biopharma Revenue Market Share, 2024 VS 2031
9.8 Southeast Asia
9.8.1 Southeast Asia AI in Biopharma Market Size, 2020-2031
9.8.2 By Company, Southeast Asia AI in Biopharma Revenue Market Share, 2024
9.8.3 by Type, Southeast Asia AI in Biopharma Revenue Market Share, 2024 VS 2031
9.8.4 by Application, Southeast Asia AI in Biopharma Revenue Market Share, 2024 VS 2031
9.9 India
9.9.1 India AI in Biopharma Market Size, 2020-2031
9.9.2 By Company, India AI in Biopharma Revenue Market Share, 2024
9.9.3 by Type, India AI in Biopharma Revenue Market Share, 2024 VS 2031
9.9.4 by Application, India AI in Biopharma Revenue Market Share, 2024 VS 2031
9.10 Middle East & Africa
9.10.1 Middle East & Africa AI in Biopharma Market Size, 2020-2031
9.10.2 By Company, Middle East & Africa AI in Biopharma Revenue Market Share, 2024
9.10.3 by Type, Middle East & Africa AI in Biopharma Revenue Market Share, 2024 VS 2031
9.10.4 by Application, Middle East & Africa AI in Biopharma Revenue Market Share, 2024 VS 2031

10 Company Profile
10.1 Recursion Pharmaceuticals
10.1.1 Recursion Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
10.1.2 Recursion Pharmaceuticals Company Profile and Main Business
10.1.3 Recursion Pharmaceuticals AI in Biopharma Models, Specifications, and Application
10.1.4 Recursion Pharmaceuticals AI in Biopharma Revenue and Gross Margin, 2020-2025
10.1.5 Recursion Pharmaceuticals Recent Developments
10.2 Exscientia
10.2.1 Exscientia Company Information, Head Office, Market Area, and Industry Position
10.2.2 Exscientia Company Profile and Main Business
10.2.3 Exscientia AI in Biopharma Models, Specifications, and Application
10.2.4 Exscientia AI in Biopharma Revenue and Gross Margin, 2020-2025
10.2.5 Exscientia Recent Developments
10.3 XtalPi
10.3.1 XtalPi Company Information, Head Office, Market Area, and Industry Position
10.3.2 XtalPi Company Profile and Main Business
10.3.3 XtalPi AI in Biopharma Models, Specifications, and Application
10.3.4 XtalPi AI in Biopharma Revenue and Gross Margin, 2020-2025
10.3.5 XtalPi Recent Developments
10.4 Schrödinger
10.4.1 Schrödinger Company Information, Head Office, Market Area, and Industry Position
10.4.2 Schrödinger Company Profile and Main Business
10.4.3 Schrödinger AI in Biopharma Models, Specifications, and Application
10.4.4 Schrödinger AI in Biopharma Revenue and Gross Margin, 2020-2025
10.4.5 Schrödinger Recent Developments
10.5 Owkin
10.5.1 Owkin Company Information, Head Office, Market Area, and Industry Position
10.5.2 Owkin Company Profile and Main Business
10.5.3 Owkin AI in Biopharma Models, Specifications, and Application
10.5.4 Owkin AI in Biopharma Revenue and Gross Margin, 2020-2025
10.5.5 Owkin Recent Developments
10.6 Evogene
10.6.1 Evogene Company Information, Head Office, Market Area, and Industry Position
10.6.2 Evogene Company Profile and Main Business
10.6.3 Evogene AI in Biopharma Models, Specifications, and Application
10.6.4 Evogene AI in Biopharma Revenue and Gross Margin, 2020-2025
10.6.5 Evogene Recent Developments
10.7 BioNTech
10.7.1 BioNTech Company Information, Head Office, Market Area, and Industry Position
10.7.2 BioNTech Company Profile and Main Business
10.7.3 BioNTech AI in Biopharma Models, Specifications, and Application
10.7.4 BioNTech AI in Biopharma Revenue and Gross Margin, 2020-2025
10.7.5 BioNTech Recent Developments
10.8 MedySapiens
10.8.1 MedySapiens Company Information, Head Office, Market Area, and Industry Position
10.8.2 MedySapiens Company Profile and Main Business
10.8.3 MedySapiens AI in Biopharma Models, Specifications, and Application
10.8.4 MedySapiens AI in Biopharma Revenue and Gross Margin, 2020-2025
10.8.5 MedySapiens Recent Developments

11 Conclusion

12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer

According to YH Research, the global market for AI in Biopharma should grow from US$ 1098 million in 2024 to US$ 2023 million by 2031, with a CAGR of 9.9% for the period of 2025-2031.

AI in Biopharma refers to the application of Artificial Intelligence (AI) and its sub-fields, particularly Machine Learning (ML) and Deep Learning (DL), to transform and accelerate processes across the entire biopharmaceutical value chain. This includes leveraging algorithms to analyze vast and complex biological, chemical, genetic, and clinical datasets to make predictions, recommendations, and automate tasks. The primary goal is to significantly improve the efficiency, speed, and success rate of drug discovery, target identification, compound optimization, clinical trial design, manufacturing, and personalized medicine, ultimately reducing costs and bringing novel therapies to patients faster.

AI in Biopharma

According to YH Research, the global market for AI in Biopharma should grow from US$ 1098 million in 2024 to US$ 2023 million by 2031, with a CAGR of 9.9% for the period of 2025-2031.

Unit: US$ M

www.yhresearch.com

In-depth insight into market trends

China AI in Biopharma market should grow from US$ million in 2024 to US$ million by 2031, with a CAGR of % for the period of 2025-2031.

The United States AI in Biopharma market should grow from US$ million in 2024 to US$ million by 2031, with a CAGR of % for the period of 2025-2031.

In terms of product type, Machine Learning (ML) & Deep Learning (DL) segment holds a share about % in 2024, and will reach % in 2031; while in terms of end use, Drug Development has a share approximately % in 2024, and will grow at a CAGR % during 2025 and 2031.

The global key manufacturers of AI in Biopharma include Recursion Pharmaceuticals, Exscientia, XtalPi, Schrödinger, Owkin, Evogene, BioNTech, MedySapiens, etc. In 2024, the global top five players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive study of the global market for AI in Biopharma. Report Highlights:
(1) Global AI in Biopharma market size (value), history data from 2020-2024, and forecast data from 2025 to 2031.

(2) Global AI in Biopharma market competitive situation, revenue, and market share, from 2020 to 2024.

(3) China AI in Biopharma market competitive situation, revenue, and market share, from 2020 to 2024.

(4) Global AI in Biopharma segment by region (or country), key regions cover the United States, Europe, China, Japan, South Korea, Southeast Asia, and India, etc.

(5) Global AI in Biopharma segment by Type, and by Application, and regional segment by Type, and by Application.

(6) AI in Biopharma industry supply chain, upstream, midstream, and downstream analysis.

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by Type, covers
Machine Learning (ML) & Deep Learning (DL)
Natural Language Processing (NLP)
Others

Market segment by Research Direction, covers
Drug Discovery & Development
Genomics & Precision Medicine
Medical Imaging & Diagnostics
Others

Market segment by Application, can be divided into
Drug Development
Disease Diagnosis and Treatment
Other

Market segment by players, this report covers
Recursion Pharmaceuticals
Exscientia
XtalPi
Schrödinger
Owkin
Evogene
BioNTech
MedySapiens